Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer.

Surgical oncology - 1 Sept 2017

Pérez-Ramírez Cristina, Cañadas-Garre Marisa, Alnatsha Ahmed, Molina Miguel Ángel, Robles Ana I, Villar Eduardo, Delgado Juan Ramón, Faus-Dáder María José, Calleja-Hernández Miguel Ángel

Abstract excerpt

BACKGROUND: Surgery is the standard treatment for early-stage NSCLC, and platinum-based chemotherapy remains as the treatment of choice for advanced-stage NSCLC patients with naïve EGFR status. However, overall 5-years relative survival rates are low. Interleukins (ILs) are crucial for processes associated with tumor development. In NSCLC, IL1B, IL6, IL12A, IL13 and IL16 gene polymorphisms may contribute to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Early Detection of Cancer

Share to Interleukin-16

Share to Interleukins

Share to Kaplan-Meier Estimate

Share to Lung Neoplasms

Source

Identifiers

PMID: 28807247
DOI: 10.1016/j.suronc.2017.05.004

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer.PMID 28807247Read ↗

Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer.Semantic proximity Read ↗

Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients.Semantic proximity Read ↗

IL-6 polymorphism in non-small cell lung cancer: a prognostic value?Semantic proximity Read ↗

Impact of IL-6 and IL-1β Gene Variants on Non-small-cell Lung Cancer Risk in Egyptian Patients.Semantic proximity Read ↗

Interleukin polymorphisms and protein levels associated with lung cancer susceptibility and phenotypes.Semantic proximity Read ↗

Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.Semantic proximity Read ↗

Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study.Semantic proximity Read ↗

IL1B gene polymorphisms, age and the risk of non-small cell lung cancer in a Chinese population.Semantic proximity Read ↗

Genetic polymorphisms of IL-10, IL-18 and IL12B are associated with risk of non-small cell lung cancer in a Chinese Han population.Semantic proximity Read ↗

Associations of IL6 rs1800795, BLK rs13277113, TIMP3 rs9621532, IL1RL1 rs1041973 and IL1RAP rs4624606 single gene polymorphisms with laryngeal squamous cell carcinoma.Semantic proximity Read ↗

Interleukin-6 -634C/G polymorphism is associated with lung cancer risk: a meta-analysis.Semantic proximity Read ↗

Correlation analysis between an IL-6 genetic polymorphism and non-small cell lung cancer prognosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.